latrepirdine has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharadwaj, P; Groth, D; Laws, SM; Martins, RN; Paxman, A; Porter, T; Verdile, G | 1 |
| Ankarcrona, M; Hedskog, L; Petersen, CA; Winblad, B; Zhang, S | 1 |
2 other study(ies) available for latrepirdine and Neuroblastoma
| Article | Year |
|---|---|
The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity.
Topics: Amyloid beta-Peptides; Analysis of Variance; Antipsychotic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Humans; Indoles; L-Lactate Dehydrogenase; Microscopy, Atomic Force; Neuroblastoma; Peptide Fragments; Protein Aggregates | 2016 |
Dimebon (latrepirdine) enhances mitochondrial function and protects neuronal cells from death.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Blood Proteins; Calcium; Cell Differentiation; Cell Line, Tumor; DNA, Mitochondrial; Gene Dosage; Humans; Indoles; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neuroblastoma; Neurons; Neuroprotective Agents; Tretinoin | 2010 |